DORITHRICIN THROAT LOZENGES

国: シンガポール

言語: 英語

ソース: HSA (Health Sciences Authority)

有効成分:

BENZALKONIUM CHLORIDE; BENZOCAINE; TYROTHRICIN

から入手可能:

HYPHENS PHARMA PTE. LTD.

ATCコード:

R02AA20

投薬量:

1.0 mg

医薬品形態:

LOZENGE

構図:

BENZALKONIUM CHLORIDE 1.0 mg; BENZOCAINE 1.5 mg; TYROTHRICIN 0.5 mg

投与経路:

ORAL

処方タイプ:

Pharmacy Only

製:

Medice Arzneimittel Pütter GmbH & Co. KG

認証ステータス:

ACTIVE

承認日:

1990-05-03

情報リーフレット

DORITHRICIN
® THROAT LOZENGES
Important information, read carefully!
COMPOSITION ______________ (per lozenge)
Tyrothricin _______________ 0,50 mg
Benzalkonium chloride _______ 1,00 mg
Benzocaine ________________ 1,50 mg
The other ingredients are:
Sorbitol
(Ph.
Eur.),
talc,
sucrose
stearate
type
III,
saccharin-sodium
2H
2
O,
mint
oil,
providone (K 25), carmellose sodium
For diabetic patients: 1 lozenge contains 870,7 mg sorbitol
PROPERTIES
Dorithricin
®
Throat Lozenges are highly effective in the treatment of painful
inflammations of
the oral cavity and pharynx. They are fast painkillers due to the
proven surface anaesthetic
Benzocaine. Their high antimicrobial effect inhibits infection. The
efficacy of the specific
topical antibiotic Tyrothricin, which is germ-hindering and germicidal
and Benzalkonium
chloride,
which is
antiseptic
highly
effective
are both
directed
at
the most frequently
occurring germs which produce painful inflammations in the oral cavity
and pharynx.
By
combining
the
two
antimicrobial
active
substances,
the
main
pathogens
are
also
overcome.
Dorithricin
®
Throat Lozenges are well-tolerated, conducive to mucosa regeneration,
and
speed up the healing process.
INDICATIONS
Sore
throat,
stomatitis
(inflammation
of
the
mouth),
pharyngitis
(inflammation
of
the
pharynx), laryngitis (inflammation of the larynx), gingivitis
(inflammation of the gums).
CONTRAINDICATIONS
None known. Generally well-tolerated.
INCOMPATIBILITIES
None known.
DRUG INTERACTIONS
Patients that are administered local anaesthetics may be at increased
risk of developing
methaemoglobinaemia when concurrently exposed to the following
oxidizing agents:

Nitrates/Nitrites (eg. nitroglycerin, nitroprusside, nitric oxide,
nitrous oxide)

Local
anaesthetics
(eg.
lidocaine,
bupivacaine,
mepivacaine,
tetracaine,
prilocaine,
procaine, articaine)

Antineoplastic
agents
(eg.
cyclophosphamide,
flutamide,
rasburicase,
isofamide,
hydroxyurea)

Antibiotics (eg. dapsone, sulphonamides, nitrofurantoin,
para-aminosalicylic acid)

Anti